ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

PerkinElmer Acquires Imaging Firm VisEn

by Marc S. Reisch
August 9, 2010 | APPEARED IN VOLUME 88, ISSUE 32

PerkinElmer has acquired VisEn Medical, a Bedford, Mass.-based in vivo molecular imaging technology firm with about 50 employees. No financial details are available. PerkinElmer says the acquisition will expand its product offerings for preclinical research at academic institutes and pharmaceutical firms. VisEn’s fluorescence molecular imaging systems and reagents are used for cancer research as well as for investigations into inflammatory, cardiovascular, skeletal, and pulmonary diseases.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment